Community Acquired Pneumonia – Pipeline Review including key players Biotest AG,InflaRx NV,ioGenetics

Community Acquired Pneumonia – Pipeline Review
Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a hospital or long-term care facility. Symptoms include cough, fever, shaking chills, confusion, headache and loss of appetite. Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis and diabetes mellitus. Treatment includes antibiotics and healthy lifestyle.

A new independent 121 page research with title ‘Community Acquired Pneumonia – Pipeline Review, H2 2018’ guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions and important players/vendors such as Biotest AG,InflaRx NV,ioGenetics Inc,Kyorin Pharmaceutical Co Ltd,Meiji Seika Pharma Co Ltd,Melinta Therapeutics Inc,Merck & Co Inc. With n-number of tables and figures examining the Community Acquired Pneumonia the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2022

 

HTF latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia – Pipeline Review, H2 2018, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline landscape.

 

Request a sample report @ https://www.htfmarketreport.com/sample-report/1262564-community-acquired-pneumonia-pipeline-review-5

 

Report Highlights

 

HTF Pharmaceutical and Healthcare latest pipeline guide Community Acquired Pneumonia – Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Community Acquired Pneumonia (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

 

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/1262564-community-acquired-pneumonia-pipeline-review-5

 

The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 5, 1, 1, 6, 2, 2 and 1 respectively.

                                                      

Community Acquired Pneumonia (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

 

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Community Acquired Pneumonia (Infectious Disease).

– The pipeline guide reviews pipeline therapeutics for Community Acquired Pneumonia (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Community Acquired Pneumonia (Infectious Disease) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Community Acquired Pneumonia (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Community Acquired Pneumonia (Infectious Disease)

 

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Community Acquired Pneumonia (Infectious Disease).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Community Acquired Pneumonia (Infectious Disease) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

 

Companies Mentioned in the Report

Biotest AG

InflaRx NV

ioGenetics Inc

Kyorin Pharmaceutical Co Ltd

Meiji Seika Pharma Co Ltd

Melinta Therapeutics Inc

Merck & Co Inc

Nabriva Therapeutics plc

Paratek Pharmaceuticals Inc

ProThera Biologics Inc

TaiGen Biotechnology Co Ltd

Takeda Pharmaceutical Co Ltd

Tetraphase Pharmaceuticals Inc

TiGenix NV

Wockhardt Ltd

 

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1262564-community-acquired-pneumonia-pipeline-review-5

 

 

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Community Acquired Pneumonia – Overview

Community Acquired Pneumonia – Therapeutics Development

Pipeline Overview

Pipeline by Companies

 

….Continued

 

 

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

 

 

Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=1262564

 

 

Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States
Website: www.htfmarketreport.com/reports/1262564-community-acquired-pneumonia-pipeline-review-5